McKesson takeover of Celesio back on
Celesio, the parent company of Lloydspharmacy and AAH, has been bought by McKesson, a large US drug distributor, despite the takeover bid initially falling through last week.
McKesson has now secured ownership of 75 per cent of Celesio shares and the deal is expected to be completed within 10 days. John Hammergen, chairman and chief executive of McKesson, said: “We look forward to bringing together the strengths of the McKesson and Celesio organisations so we can provide our customers with more efficient delivery of healthcare products and services around the world. Our customers will benefit from the increased scale, supply chain expertise and sourcing capabilities of the combined company, together with enhanced access to innovative technology and business services.”
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11133311
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com